1Neuro faces of beneficial T cells:essential in brain,impaired in aging and neurological diseases,and activated functionally by neurotransmitters and neuropeptidesMia LeviteReviews1165-1178
2Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases:a systematic reviewKah Hui Yap，Shahrul Azmin，Suzana Makpol，Hanafi Ahmad Damanhuri，Muzaimi Mustapha，Jemaima Che Hamzah，Norlinah Mohamed IbrahimReviews1179-1185
3Cdk5 and aberrant cell cycle activation at the core of neurodegenerationRaquel Requejo-AguilarReviews1186-1190
4Recent advancements in noninvasive brain modulation for individuals with autism spectrum disorderJessica R.Griff，Jake Langlie，Nathalie B.Bencie，Zachary J.Cromar，Jeenu Mittal，Idil Memis，Steven Wallace，Alexander E.Marcillo，Rahul Mittal，Adrien A.EshraghiReviews1191-1195
5Vicious cycle of lipid peroxidation and iron accumulation in neurodegenerationIrene Villalón-García，Suleva Povea-Cabello，Mónica álvarez-Córdoba，Marta Talaverón-Rey，Juan M.Suárez-Rivero，Alejandra Suarez-Carrillo，Manuel Munuera-Cabeza，Diana Reche-López，Paula Cilleros-Holgado，Rocío Pi?ero-Pérez，José A.Sánchez-AlcázarReviews1196-1202
6Cell-based therapeutic strategies for treatment of spinocerebellar ataxias:an updateJoana Sofia Correia，Sara Duarte-Silva，António José Salgado，Patrícia MacielReviews1203-1212
7Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?Zhengtao Hu，Tomas Ondrejcak，Pengpeng Yu，Yangyang Zhang，Yin Yang，Igor Klyubin，Sean P.Kennelly，Michael J.Rowan，Neng-Wei HuReviews1213-1219
8Neurotrophic factor-based pharmacological approaches in neurological disordersMargherita Alfonsetti，Michele d'Angelo，Vanessa CastelliReviews1220-1228
9Translational bioengineering strategies for peripheral nerve regeneration:opportunities,challenges,and novel conceptsKarim A.Sarhane，Chenhu Qiu，Thomas G.W.Harris，Philip J.Hanwright，Hai-Quan Mao，Sami H.TuffahaReviews1229-1234
10Decoding degeneration:the implementation of machine learning for clinical detection of neurodegenerative disordersFariha Khaliq，Jane Oberhauser，Debia Wakhloo，Sameehan MahajaniReviews1235-1242
11Long-noncoding RNAs as epigenetic regulators in neurodegenerative diseasesPaola Ruffo，Francesca De Amicis，Emiliano Giardina，Francesca Luisa ConfortiReviews1243-1248
12The lymphatic system:a therapeutic target for central nervous system disordersJia-Qi Xu，Qian-Qi Liu，Sheng-Yuan Huang，Chun-Yue Duan，Hong-Bin Lu，Yong Cao，Jian-Zhong HuReviews1249-1256
13Plasticity of callosal neurons in the contralesional cortex following traumatic brain injuryAlexandra Chovsepian，Laura Empl，Florence M.BareyrePerspectives1257-1258
14Molecular mechanisms of lesion-induced axonal sprouting in the corticofugal projection:the role of glial cellsLeechung Chang，Nobuhiko YamamotoPerspectives1259-1260
15Targeting neuroinflammation after therapeutic hypothermia for perinatal hypoxic-ischemic brain injuryKelly Q.Zhou，Joanne O.DavidsonPerspectives1261-1262
16Ketamine,a trauma analgesic with sex-specific immunomodulatory functionHaley F.Spencer，Rina Y.Berman，Martin Boese，Kwang H.ChoiPerspectives1263-1264
17Neural regeneration research model to be explored:SH-SY5Y human neuroblastoma cellsLavynia Ferreira Hoffmann，Alexandre Martins，Fernanda Majolo，Ver?nica Contini，Stefan Laufer，Márcia Inês GoettertPerspectives1265-1266
18cGMP signaling:a potential therapeutic target for neurodegeneration in glaucoma?Joseph M.Holden，Lauren K.WarehamPerspectives1267-1268
19Putting PLX5622 into perspective:microglia in central nervous system viral infectionAlanna G.Spiteri，Nicholas J.C.KingPerspectives1269-1270
20Nature can still be the strongest help against aging and neurodegeneration:the sirtuins wayDavid Della-Morte，Francesca PacificiPerspectives1271-1272
